Rs.119.30for 1 bottle(s) (10 ml Nasal Drops each)
1
Unfortunately, we don't have any more items in stock
Report Error

Composition FOR Vilco 0.5mg Nasal Drops

Oxymetazoline(0.5mg)

food interaction for Vilco Nasal Drops

alcohol interaction for Vilco Nasal Drops

pregnancy interaction for Vilco Nasal Drops

lactation interaction for Vilco Nasal Drops

food
alcohol
pregnancy
lactation
No interaction found/established
No interaction found/established
Vilco Nasal Drops is generally considered safe to use during pregnancy. Animal studies do not indicate harmful effects. However, there are limited human studies.
SAFE IF PRESCRIBED
Information regarding the use of Vilco Nasal Drops during breastfeeding is not available. Please consult your doctor.
CONSULT YOUR DOCTOR

SALT INFORMATION FOR Vilco 0.5mg Nasal Drops

Oxymetazoline(0.5mg)

Vilco nasal drops uses

{med_name} is used in the treatment of nasal congestion. It treats congestion associated with allergies, hay fever, sinus irritation, and the common cold.

How vilco nasal drops works

Vilco Nasal Drops is a nasal decongestant. It works by narrowing the small blood vessels in the inner surface of the nose. This provides temporary relief from congestion or stuffiness in the nose.

Common side effects of vilco nasal drops

Dryness, Dry throat, Irritation, Sneezing

SUBSTITUTES FOR Vilco Nasal Drops

2 Substitutes
2 Substitutes
Sorted By
RelevancePrice
  • Cinus 0.5mg Nasal Drops
    (10 ml Nasal Drops in packet)
    Rs. 2.32/ml of Nasal Drops
    generic_icon
    Rs. 23.44
    save 81% more per ml of Nasal Drops
  • Clinovin 0.5mg Nasal Drops
    (10 ml Nasal Drops in bottle)
    Rs. 5.11/ml of Nasal Drops
    generic_icon
    Rs. 51.56
    save 57% more per ml of Nasal Drops

Expert advice FOR Vilco Nasal Drops

  • Oxymetazoline works right away, and each dose provides relief for up to 12 hours. 
  • Shake the bottle before using the medicine, and clean your nose thoroughly before using the medicine.
  • Avoid deep breathing as it will cause medication to go back to the throat and make it less effective.
  • Do not share the bottle with anyone else so that you do not spread germs.
  • Oxymetazoline can make nasal congestion worse if used for more than 3 or 4 days in a row (called rebound congestion).

Frequently asked questions FOR Vilco 0.5mg Nasal Drops

Oxymetazoline

Q. Is Vilco Nasal Drops addictive?
Treatment with Vilco Nasal Drops does not cause mental addiction. However, patients may get physically addicted such that they may feel an urge to use Vilco Nasal Drops. Hence, it should only be used at prescribed doses for the prescribed duration as advised by your doctor.
Q. Is Vilco Nasal Drops a steroid/antihistamine?
No, Vilco Nasal Drops is not a steroid or an antihistamine. It belongs to a class of medications called adrenergic medicines that are used as nasal decongestants (to relieve congestion of the nose).
Q. Is Vilco Nasal Drops safe?
Vilco Nasal Drops is safe if used in the dose and duration advised by your doctor. Take it exactly as directed and do not skip any dose. Follow your doctor's instructions carefully and let your doctor know if any of the side effects bother you.
Show More
Q. Does Vilco Nasal Drops cause cataract/keep you awake/raise blood pressure/insomnia/drowsiness?
There are no such reports that suggest the occurrence of side effects such as cataract, insomnia (inability to sleep), or drowsiness during treatment with Vilco Nasal Drops. However, Vilco Nasal Drops can raise blood pressure when taken with medicines that are used to treat depression, like selegiline and moclobemide. It can also decrease the effect of medicines used to treat blood pressure. Hence, patients should consult doctors regarding the possible side effects and drug interactions.
Q. Can I take Vilco Nasal Drops with diphenhydramine/phenylephrine/pseudoephedrine?
Vilco Nasal Drops should not be taken simultaneously with diphenhydramine/phenylephrine/pseudoephedrine. Consult your doctor before using any other medicine with Vilco Nasal Drops.

Content on this page was last updated on 19 March, 2026, by Dr. Rajeev Sharma (MBA, MBBS)